Lifestyle Delivery Systems Inc. announces CSPA Group Inc. and LDS Scientific’s Launch of the New Luxury Product Line Rêveur

Vancouver, British Columbia, Canada, March 22, 2018, Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) (“LDS” or the “Company”) announces launch of Rêveur, a new luxury brand of cannabis products for the California medical cannabis market.

CSPA Group Inc. has received all required third-party testing results for the new Rêveur product line which confirmed zero pesticides and zero residual solvents. The test also revealed high levels of terpenes (up to 13%) and THC levels in the mid 80% range. Completion of the required testing now allows for distribution of the product line in selected retail stores in California. CSPA Group is managed by the Company’s subsidiary, LDS Scientific Inc. CSPA Group and LDS Scientific conducted a product informational seminar for distributors in both Southern and Northern California. The resulting orders will be delivered this month after all required transportation, distribution and retailer verifications have been received and processed into the track-and-trace system for the State of California. Brad Eckenweiler, LDS’s CEO, remarked, “The Rêveur product launch marks a significant milestone in the Company’s development. The response to the new product line from distributors was very encouraging and clearly supports the Company’s decision to add an additional revenue component derived from the Company’s extraction expertise.” The Company will update the market with the selected retailers, and their locations in California, where the Rêveur product line can be purchased as that information becomes available.

About Lifestyle Delivery Systems Inc.

Lifestyle Delivery Systems Inc. is a licensed, state-compliant vertically integrated cannabis-related company.  From our isogenic pollination nursery to our cutting edge, state-of-the-art production facility located in Southern California, LDS has become one of the most diverse, innovative and scientifically based cannabis companies throughout North America. The Company’s technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking but also a new way to accurately meter the dosage and assure the purity of the product. From start to finish, the production process tests for quality and composition of all the ingredients used in each and every strip, resulting in a delivery system that is safe, consistent and effective.

On behalf of the board of directors of Lifestyle Delivery Systems Inc.

Brad Eckenweiler

CEO & Director

FOR MORE INFORMATION, PLEASE CONTACT:

[email protected]

1-866-347-5058

Cautionary Disclaimer Statement:

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970.  Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect.  Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.